The commercialization of bioprinted products and procedures raises questions about ownership and profit distribution. Ethical approaches should ensure that intellectual property laws do not hinder access to essential health interventions for women or exploit their biological contributions.
- Log in or register to contribute
Contribute to three or more articles across any domain to qualify for the Contributor badge. Please check back tomorrow for updates on your progress.